Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Non Operating Income (2022 - 2025)

Praxis Precision Medicines has reported Non Operating Income over the past 4 years, most recently at $8.1 million for Q4 2025.

  • Quarterly results put Non Operating Income at $8.1 million for Q4 2025, up 54.12% from a year ago — trailing twelve months through Dec 2025 was $22.9 million (up 32.19% YoY), and the annual figure for FY2025 was $22.9 million, up 32.19%.
  • Non Operating Income for Q4 2025 was $8.1 million at Praxis Precision Medicines, up from $4.4 million in the prior quarter.
  • Over the last five years, Non Operating Income for PRAX hit a ceiling of $8.1 million in Q4 2025 and a floor of $132000.0 in Q1 2022.
  • Median Non Operating Income over the past 4 years was $1.6 million (2023), compared with a mean of $2.8 million.
  • Biggest five-year swings in Non Operating Income: skyrocketed 642.44% in 2024 and later dropped 10.15% in 2025.
  • Praxis Precision Medicines' Non Operating Income stood at $280000.0 in 2022, then skyrocketed by 231.43% to $928000.0 in 2023, then soared by 468.64% to $5.3 million in 2024, then soared by 54.12% to $8.1 million in 2025.
  • The last three reported values for Non Operating Income were $8.1 million (Q4 2025), $4.4 million (Q3 2025), and $4.9 million (Q2 2025) per Business Quant data.